298 related articles for article (PubMed ID: 32629772)
1. Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis.
Karami M; Hemradj VV; Ouweneel DM; den Uil CA; Limpens J; Otterspoor LC; Vlaar AP; Lagrand WK; Henriques JPS
J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32629772
[TBL] [Abstract][Full Text] [Related]
2. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock.
Shabana A; Dholoo F; Banerjee P
Curr Heart Fail Rep; 2020 Dec; 17(6):438-448. PubMed ID: 33103204
[TBL] [Abstract][Full Text] [Related]
3. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Uhlig K; Efremov L; Tongers J; Frantz S; Mikolajczyk R; Sedding D; Schumann J
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009669. PubMed ID: 33152122
[TBL] [Abstract][Full Text] [Related]
4. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
[TBL] [Abstract][Full Text] [Related]
5. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
[TBL] [Abstract][Full Text] [Related]
6. Inotropes, vasopressors, and mechanical circulatory support for treatment of cardiogenic shock complicating myocardial infarction: a systematic review and network meta-analysis.
Fernando SM; Mathew R; Sadeghirad B; Brodie D; Belley-Côté EP; Thiele H; van Diepen S; Fan E; Di Santo P; Simard T; Russo JJ; Tran A; Lévy B; Combes A; Hibbert B; Rochwerg B
Can J Anaesth; 2022 Dec; 69(12):1537-1553. PubMed ID: 36195825
[TBL] [Abstract][Full Text] [Related]
7. Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database.
Sasmita BR; Wang C; Xie S
Front Cardiovasc Med; 2023; 10():1300839. PubMed ID: 38094120
[TBL] [Abstract][Full Text] [Related]
8. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
Hu K; Mathew R
Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive pharmacologic therapy in cardiogenic shock: a critical review.
Kaddoura R; Elmoheen A; Badawy E; Eltawagny MF; Seif MA; Bashir K; Salam AM
J Drug Assess; 2021; 10(1):68-85. PubMed ID: 34350058
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trials of patients with acute myocardial infarction-related cardiogenic shock: a systematic review of used cardiogenic shock definitions and outcomes.
Josiassen J; Frydland M; Hassager C; Møller JE; Perner A; Grand J
Kardiol Pol; 2021; 79(9):1003-1015. PubMed ID: 34292563
[TBL] [Abstract][Full Text] [Related]
11. "Assessing the hemodynamic impact of various inotropes combination in patients with cardiogenic shock with Non-ST elevation myocardial infarction -the ANAPHOR study".
Sharma K; Charaniya R; Champaneri B; Bhatia S; Sharma V; Mansuri Z; Panakkal BJ; Thakkar H; Patel K
Indian Heart J; 2021; 73(5):572-576. PubMed ID: 34627571
[TBL] [Abstract][Full Text] [Related]
12. Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated With the Impella Device.
Rohm CL; Gadidov B; Ray HE; Mannino SF; Prasad R
Cardiovasc Revasc Med; 2021 Oct; 31():71-75. PubMed ID: 33309042
[TBL] [Abstract][Full Text] [Related]
13. The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials.
Belletti A; Castro ML; Silvetti S; Greco T; Biondi-Zoccai G; Pasin L; Zangrillo A; Landoni G
Br J Anaesth; 2015 Nov; 115(5):656-75. PubMed ID: 26475799
[TBL] [Abstract][Full Text] [Related]
14. A goal-oriented hemodynamic approach to acute myocardial infarction complicated by cardiogenic shock-A single center experience.
Siebert V; Goldstein J; Khan R; Lopez J; Darki A; Lewis B; Steen L; Doukas D
Catheter Cardiovasc Interv; 2023 Oct; 102(4):569-576. PubMed ID: 37548088
[TBL] [Abstract][Full Text] [Related]
15. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
Levy B; Buzon J; Kimmoun A
Curr Opin Crit Care; 2019 Aug; 25(4):384-390. PubMed ID: 31166204
[TBL] [Abstract][Full Text] [Related]
16. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
[TBL] [Abstract][Full Text] [Related]
17. The concomitant use of ultra short beta-blockers with vasopressors and inotropes in critically ill patients with septic shock: A systematic review and meta-analysis of randomized controlled trials.
Al Sulaiman K; Alkofide HA; AlFaifi ME; Aljohani SS; Al Harthi AF; Alqahtani RA; Alanazi AM; Nazer LH; Al Shaya AI; Aljuhani O
Saudi Pharm J; 2024 Jun; 32(6):102094. PubMed ID: 38812943
[TBL] [Abstract][Full Text] [Related]
18. Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
Javaid AI; Michalek JE; Gruslova AB; Hoskins SA; Ahsan CH; Feldman MD
Catheter Cardiovasc Interv; 2024 Jan; 103(1):30-41. PubMed ID: 37997292
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Milrinone and Dobutamine in Cardiogenic Shock: An Updated Systematic Review and Meta-Analysis.
Abdel-Razek O; Di Santo P; Jung RG; Parlow S; Motazedian P; Prosperi-Porta G; Visintini S; Marbach JA; Ramirez FD; Simard T; Labinaz M; Mathew R; Hibbert B
Crit Care Explor; 2023 Sep; 5(9):e0962. PubMed ID: 37649849
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan in patients with cardiogenic shock complicating myocardial infarction: A meta-analysis.
Fang M; Cao H; Wang Z
Med Intensiva (Engl Ed); 2018 Oct; 42(7):409-415. PubMed ID: 29126662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
